Granules India Share Price
CMP as on 17-Sep-21 12:28
₹ 327.65Open
₹ 334.50Turnover (lac)
₹ 4,071Prev. Close
₹ 333.00Day's Vol (shares)
₹ 12,42,476CMP as on17-Sep-21 12:28
₹ 327.40Open
₹ 332.95Turnover (lac)
₹ 447Prev. Close
₹ 332.95Day's Vol (shares)
₹ 72,941News
-
Granules India issues voluntary recall of one batch of Naproxen Sodium 220mg tab
16:12 IST, Sep 13One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled du
-
Granules India declines on voluntary recalling batch of naproxen sodium tablets
12:18 IST, Sep 13Granules India slipped 1.19% to Rs 324.35 after the company said that it is voluntarily recalling one batch of naproxen sodium 220mg ta
-
Granules USA recalls one batch of Naproxen Sodium 220mg tablets
11:59 IST, Sep 13Granules USA recalls one batch of Naproxen Sodium 220mg tablets
-
Granules India receives license from DRDO to manufacture and market 2-DG
9:41 IST, Sep 032- Deoxy-D-Glucose has been granted permission by DCGI for emergency use of this drug as an adjunct therapy in moderate to severe Covid
-
Granules India gains after DRDO license to manufacture, market 2-DG COVID drug
9:23 IST, Sep 03Granules India rose 1.70% after the company said that it has received licence from Defence Research & Development Organisation (DRDO),
-
Health Canada approves Granules India's Acetaminophen extended-release tablets
17:00 IST, Aug 30The product manufactured by Granules is bioequivalent to the reference listed drug, Tylenol Extended-Release 650 Tablets.
-
Health Canada approves Granules Acetaminophen ER Tablets
13:05 IST, Aug 30Health Canada approves Granules Acetaminophen ER Tablets
-
Granules India rises after Health Canada approval for acetaminophen tablets
12:03 IST, Aug 30Granules India rose 1.28% to Rs 334.75 after the drug maker announced receiving marketing approval from Health Canada for acetaminophen
-
Volumes soar at Granules India Ltd counter
11:00 IST, Aug 02Granules India Ltd clocked volume of 25.32 lakh shares by 10:50 IST on BSE, a 8.3 times surge over two-week average daily volume of 3.0
-
Granules spurts after Q1 PAT rises 8% YoY to Rs 120 cr
10:40 IST, Jul 28Granules India rose 1.41% to Rs 369.85 after the drug company posted a 7.9% rise in consolidated net profit to Rs 120.2 crore on a 15.5
QuickLinks for Granules India Ltd.
